Position in GILD
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$17,092,791
-$2,313,505 QoQ
Shares Held
135,292
-2.8% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.47%
of 13F equity value
Holder Rank
#348
of 2,266 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RITHOLTZ WEALTH MANAGEMENT holds $147,518,356 across 14 Drug Manufacturers - General names. GILD ranks #3 (11.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
22,420 | $26,891,222 | |
| 2 | JNJ |
Johnson & Johnson
|
101,232 | $25,709,891 | |
| 3 | GILD |
Gilead Sciences, Inc.
This page
|
135,292 | $17,092,791 | |
| 4 | NVS |
Novartis AG
|
105,819 | $16,583,953 | |
| 5 | ABBV |
AbbVie Inc.
|
49,487 | $12,452,908 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
169,475 | $9,765,149 | |
| 7 | BIIB |
Biogen Inc.
|
34,283 | $7,407,184 | |
| 8 | AZN |
Astrazeneca PLC
|
34,429 | $6,528,426 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $17,092,791 | 135,292 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $19,406,296 | 139,243 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $16,608,931 | 135,318 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $14,147,283 | 127,453 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $12,768,454 | 115,166 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $11,478,402 | 102,440 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $8,149,620 | 88,228 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $4,094,913 | 48,842 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $3,068,033 | 44,717 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $4,391,630 | 59,954 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $5,188,042 | 64,042 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $4,674,907 | 62,382 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $4,914,908 | 63,772 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $5,433,290 | 65,485 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $5,877,119 | 68,458 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $3,616,637 | 58,626 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $543,248 | 8,789 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $388,208 | 6,530 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $712,013 | 9,806 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $614,191 | 8,793 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $547,850 | 7,956 | Shares | Sole | 2021-07-20 | |
| 2021-03-31 | $517,880 | 8,013 | Shares | Sole | 2021-05-12 | |
| 2020-09-30 | $243,723 | 3,857 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $312,145 | 4,057 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $218,523 | 2,923 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||